[go: up one dir, main page]

NO20054180L - Behandling av bakterielle sykdommer i andedrettsorganene ved lokal tilforsel av fluorkinoloner - Google Patents

Behandling av bakterielle sykdommer i andedrettsorganene ved lokal tilforsel av fluorkinoloner

Info

Publication number
NO20054180L
NO20054180L NO20054180A NO20054180A NO20054180L NO 20054180 L NO20054180 L NO 20054180L NO 20054180 A NO20054180 A NO 20054180A NO 20054180 A NO20054180 A NO 20054180A NO 20054180 L NO20054180 L NO 20054180L
Authority
NO
Norway
Prior art keywords
respiratory tract
fluoroquinolones
treatment
local administration
bacterial diseases
Prior art date
Application number
NO20054180A
Other languages
English (en)
Other versions
NO331524B1 (no
NO20054180D0 (no
Inventor
Rainer Endermann
Uwe Petersen
Harald Labischinski
Christoph Ladel
Ben Newton
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32851853&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20054180(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10305319A external-priority patent/DE10305319A1/de
Priority claimed from DE10305318A external-priority patent/DE10305318A1/de
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of NO20054180L publication Critical patent/NO20054180L/no
Publication of NO20054180D0 publication Critical patent/NO20054180D0/no
Publication of NO331524B1 publication Critical patent/NO331524B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er beskrevet inhalerbare kinolonkarboksylsyrederivat-sammensetninger for lokal bekjempelse av sykdommer i luftveisorganene, spesielt lungesykdommer.
NO20054180A 2003-02-10 2005-09-08 Anvendelse av ciprofloksacin betain for fremstilling av medikamenter og aerosolinnretning for administrering av fast aktivbestanddel ved inhalering. NO331524B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10305319A DE10305319A1 (de) 2003-02-10 2003-02-10 Behandlung bakteriell verursachter Lungenkrankheiten
DE10305318A DE10305318A1 (de) 2003-02-10 2003-02-10 Behandlung bakteriell verursachter Lungenkrankheiten
PCT/EP2004/000710 WO2004069253A1 (de) 2003-02-10 2004-01-28 Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen

Publications (3)

Publication Number Publication Date
NO20054180L true NO20054180L (no) 2005-09-08
NO20054180D0 NO20054180D0 (no) 2005-09-08
NO331524B1 NO331524B1 (no) 2012-01-23

Family

ID=32851853

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054180A NO331524B1 (no) 2003-02-10 2005-09-08 Anvendelse av ciprofloksacin betain for fremstilling av medikamenter og aerosolinnretning for administrering av fast aktivbestanddel ved inhalering.

Country Status (27)

Country Link
US (2) US8034817B2 (no)
EP (1) EP1594500B1 (no)
JP (2) JP4828405B2 (no)
KR (1) KR101173696B1 (no)
AR (1) AR043117A1 (no)
AT (1) ATE482706T1 (no)
AU (1) AU2004210399B2 (no)
BR (1) BRPI0407368A (no)
CA (1) CA2515262C (no)
CY (1) CY1110998T1 (no)
DE (1) DE502004011696D1 (no)
DK (1) DK1594500T3 (no)
EC (1) ECSP055959A (no)
HR (1) HRP20050786B1 (no)
IL (1) IL170027A (no)
MA (1) MA27632A1 (no)
MX (1) MXPA05008407A (no)
MY (1) MY144714A (no)
NO (1) NO331524B1 (no)
NZ (1) NZ541681A (no)
PE (1) PE20050189A1 (no)
PT (1) PT1594500E (no)
RU (1) RU2373937C9 (no)
SI (1) SI1594500T1 (no)
TW (1) TWI347843B (no)
UY (1) UY28179A1 (no)
WO (1) WO2004069253A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157455B2 (en) * 2003-02-10 2007-01-02 Hoffmann-La Roche Inc. 4-Aminopyrimidine-5-one derivatives
ATE482706T1 (de) * 2003-02-10 2010-10-15 Bayer Schering Pharma Ag Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen
WO2006033713A2 (en) * 2004-08-09 2006-03-30 Chiron Corporation Methods for ciprofloxacin inhalation
US8846607B2 (en) 2004-10-29 2014-09-30 President And Fellows Of Harvard College Particles for treatment of pulmonary infection
DK1901749T3 (en) * 2005-05-18 2016-10-24 Raptor Pharmaceuticals Inc Aerosolized fluoroquinolones AND USES THEREOF
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
KR101621986B1 (ko) * 2008-05-15 2016-05-17 노파르티스 아게 플루오로퀴놀론의 폐 전달
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
US8168597B2 (en) 2008-10-22 2012-05-01 Inspire Pharmaceuticals, Inc. Method for treating cystic fibrosis
EP3569235A1 (en) 2009-09-04 2019-11-20 Horizon Orphan LLC Use of aerosolized levofloxacin for treating cystic fibrosis
US9393243B1 (en) 2015-07-14 2016-07-19 Nilesh Parikh Topical Ciprofloxacin compositions
WO2018074880A2 (ko) * 2016-10-20 2018-04-26 한국화학연구원 퀴놀린 4-온 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 폐렴의 예방 또는 치료용 약학적 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3033157A1 (de) 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3525335A1 (de) * 1985-07-16 1987-01-22 Bayer Ag Embonate von chinoloncarbonsaeuren und ihren derivaten
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
FR2655545B1 (fr) * 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
RU2063770C1 (ru) * 1992-05-22 1996-07-20 Николай Сергеевич Скрипников Способ лечения гнойно-воспалительных заболеваний легких
RU2070045C1 (ru) * 1993-01-15 1996-12-10 Вячеслав Михайлович Провоторов Способ лечения хронического гнойного эндобронхита
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
DE19812160C1 (de) * 1998-03-20 1999-07-08 Bayer Ag Formkörper aus wirkstoffhaltigen thermoplastischen Polyurethanen
AU5528299A (en) * 1998-09-15 2000-04-03 Naeja Pharmaceutical Inc. Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s)
CN1188111C (zh) * 1999-10-29 2005-02-09 耐科塔医药公司 分散性得到改进的干粉组合物
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
WO2003075889A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
CA2483218C (en) * 2002-04-25 2012-07-10 Nektar Therapeutics Uk Ltd Particulate materials
ATE482706T1 (de) * 2003-02-10 2010-10-15 Bayer Schering Pharma Ag Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen

Also Published As

Publication number Publication date
US20120010215A1 (en) 2012-01-12
AU2004210399A1 (en) 2004-08-19
WO2004069253A1 (de) 2004-08-19
MY144714A (en) 2011-10-31
RU2005128132A (ru) 2006-02-10
CA2515262A1 (en) 2004-08-19
RU2373937C9 (ru) 2010-07-27
CA2515262C (en) 2013-09-03
JP4828405B2 (ja) 2011-11-30
RU2373937C2 (ru) 2009-11-27
NO331524B1 (no) 2012-01-23
DE502004011696D1 (de) 2010-11-11
MXPA05008407A (es) 2005-10-05
ECSP055959A (es) 2006-01-16
US8034817B2 (en) 2011-10-11
KR101173696B1 (ko) 2012-08-13
JP2006517210A (ja) 2006-07-20
NZ541681A (en) 2009-02-28
BRPI0407368A (pt) 2006-02-14
CY1110998T1 (el) 2015-06-11
DK1594500T3 (da) 2011-01-24
KR20050098309A (ko) 2005-10-11
JP2011173929A (ja) 2011-09-08
TWI347843B (en) 2011-09-01
EP1594500A1 (de) 2005-11-16
MA27632A1 (fr) 2005-11-01
SI1594500T1 (sl) 2011-02-28
NO20054180D0 (no) 2005-09-08
HK1089380A1 (zh) 2006-12-01
HRP20050786A2 (en) 2006-10-31
AR043117A1 (es) 2005-07-20
HRP20050786B1 (hr) 2015-01-02
TW200503716A (en) 2005-02-01
ATE482706T1 (de) 2010-10-15
IL170027A (en) 2012-02-29
AU2004210399B2 (en) 2010-02-18
UY28179A1 (es) 2004-09-30
EP1594500B1 (de) 2010-09-29
PT1594500E (pt) 2010-12-17
US20040254194A1 (en) 2004-12-16
PE20050189A1 (es) 2005-05-22

Similar Documents

Publication Publication Date Title
CY1118137T1 (el) Αερολυμενες φθοροκινολονες και χρησεις αυτων
CY1110998T1 (el) Θεραπεια βακτηριακων ασθενειων των αναπνευστικων οργανων με τοπικη εφαρμογη φθοροκινολονων
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
WO2007095156A3 (en) Taste masking of aerosolized fluoroquinolones
CY1120284T1 (el) Εκνεφωμενα αντιβιοτικα για θεραπεια με εισπνοη
MX2008016134A (es) Derivados de fenol para el tratamiento de enfermedades respiratorias.
MX2010001236A (es) Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1).
DE60331056D1 (de) 6-11 bicyclische ketolidderivate
NO20055219L (no) Nye forbindelser
NZ607408A (en) Aerosol fluoroquinolone formulations for improved pharmacokinetics
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
CY1110373T1 (el) Συνεργιστικος συνδυασμος που περιλαμβανει ροφλουμιλαστη και εναν αντιχολινεργικο παραγοντα που επιλεγεται απο αλατα τιοτροπιου για την θεραπεια αναπνευστικων ασθενειων
MX2012003007A (es) Sulfonamidas como inhibidores de las proteinas de la familia bcl-2 para el tratamiento de cancer.
MX2009010374A (es) Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos.
MX2025002790A (es) Derivados de piperidina 2-sustituidos, metodos de preparacion y usos medicinales de los mismos
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
WO2007057221A3 (en) Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases
WO2007009724A3 (en) Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments
MXPA05010161A (es) Combinacion sinergistica que comprende roflumilast y un agente anticolinergico seleccionado a partir de sales de ipratropio, oxitropio y tiotropio para el tratamiento de enfermedades respiratorias.
DE602004009079D1 (de) Carbostyril-derivative zur beschleunigten speichelabsonderung
EA201100422A1 (ru) (фенил)амиды 7-(пиперазин-1-илметил)-1h-индол-2-карбоновой кислоты и родственные соединения в качестве ингибиторов мар-киназы p38 для лечения заболеваний дыхательных путей
WO2007092436A3 (en) Compounds for treating inflammatory disorders, demyelinating disorders and cancers
UA84696C2 (ru) Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов
ATE391710T1 (de) Substituierte azetidinverbindungen als cyclooxigenase-1-cyclooxygenase-2-inhibitoren und deren herstellung und verwendung als medikament
DOP2004000816A (es) Tratamiento de enfermedades bacterianas de los organos respiratorios

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MM1K Lapsed by not paying the annual fees